SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020807
Filing Date
2017-11-01
Accepted
2017-11-01 16:31:58
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20170930.htm 10-Q 1193336
2 EX-31.1 vtvt-ex311_9.htm EX-31.1 17632
3 EX-31.2 vtvt-ex312_6.htm EX-31.2 17524
4 EX-32.1 vtvt-ex321_7.htm EX-32.1 7266
5 EX-32.2 vtvt-ex322_8.htm EX-32.2 7221
6 GRAPHIC g2017103020130976511604.jpg GRAPHIC 33508
  Complete submission text file 0001564590-17-020807.txt   4034346

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20170930.xml EX-101.INS 629943
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20170930.xsd EX-101.SCH 39051
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20170930_cal.xml EX-101.CAL 31734
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20170930_def.xml EX-101.DEF 169619
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20170930_lab.xml EX-101.LAB 293139
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20170930_pre.xml EX-101.PRE 228522
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 171169373
SIC: 2834 Pharmaceutical Preparations